Keywords: USA, Regeneron, Bayer, VEGF Trap-Eye, Advisory meeting, Advanced Aspirin

US FDA schedules advisory meeting VEGF Trap-Eye from Regeneron, Bayer; latter debuts Advanced Aspirin

Article | 25 May 2011

Print This

USA-based Regeneron Pharmaceuticals (Nasdaq: REGN) and partner German drug major Bayer (BAY: DE) say the US Food and Drug Administration ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in